Immune Responses in the Central Nervous System Are Anatomically Segregated in a Non-Human Primate Model of Human Immunodeficiency Virus Infection

The human immunodeficiency virus (HIV) accesses the central nervous system (CNS) early during infection, leading to HIV-associated cognitive impairment and establishment of a viral reservoir. Here, we describe a dichotomy in inflammatory responses in different CNS regions in simian immunodeficiency virus (SIV)-infected macaques, a model for HIV infection. We found increased expression of inflammatory genes and perivascular leukocyte infiltration in the midbrain of SIV-infected macaques. Conversely, the frontal lobe showed downregulation of inflammatory genes associated with interferon-γ and interleukin-6 pathways, and absence of perivascular cuffing. These immunologic alterations were not accompanied by differences in SIV transcriptional activity within the tissue. Altered expression of genes associated with neurotoxicity was observed in both midbrain and frontal lobe. The segregation of inflammatory responses to specific regions of the CNS may both account for HIV-associated neurological symptoms and constitute a critical hurdle for HIV eradication by shielding the CNS viral reservoir from antiviral immunity.

[1]  Roger N Gunn,et al.  Neuroinflammation in treated HIV-positive individuals , 2016, Neurology.

[2]  K. Suk,et al.  Functional polarization of neuroglia: Implications in neuroinflammation and neurological disorders. , 2016, Biochemical pharmacology.

[3]  H. Schuitemaker,et al.  Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys , 2015, Science.

[4]  K. MacDonald,et al.  A critical analysis of the cynomolgus macaque, Macaca fascicularis, as a model to test HIV-1/SIV vaccine efficacy. , 2015, Vaccine.

[5]  Mardge H. Cohen,et al.  Prefrontal cortical volume loss is associated with stress-related deficits in verbal learning and memory in HIV-infected women , 2015, Neurobiology of Disease.

[6]  R. Swanstrom,et al.  HIV-1 target cells in the CNS , 2015, Journal of NeuroVirology.

[7]  R. Swanstrom,et al.  Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS , 2015, Current HIV/AIDS Reports.

[8]  Bruce J Brew,et al.  The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication , 2015, Current HIV/AIDS Reports.

[9]  A. Winston,et al.  Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?. , 2015, AIDS.

[10]  Gregory G. Brown,et al.  Apathy is associated with white matter abnormalities in anterior, medial brain regions in persons with HIV infection , 2014, Journal of clinical and experimental neuropsychology.

[11]  Matthijs Vink,et al.  HIV infection and the fronto–striatal system: a systematic review and meta-analysis of fMRI studies , 2014, AIDS.

[12]  M. Schwartz,et al.  CNS-specific T cells shape brain function via the choroid plexus , 2013, Brain, Behavior, and Immunity.

[13]  V. Wojna,et al.  YWHAE/14-3-3ε: a potential novel genetic risk factor and CSF biomarker for HIV neurocognitive impairment , 2013, Journal of NeuroVirology.

[14]  S Spudich.  HIV and Neurocognitive Dysfunction , 2013, Current HIV/AIDS Reports.

[15]  D. Richman,et al.  Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs , 2013, The Lancet.

[16]  M. Churchill,et al.  Where does HIV hide? A focus on the central nervous system , 2013, Current opinion in HIV and AIDS.

[17]  D. Montefiori,et al.  Protection Afforded by an HIV Vaccine Candidate in Macaques Depends on the Dose of SIVmac251 at Challenge Exposure , 2013, Journal of Virology.

[18]  B. Brew,et al.  The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders , 2012, The FEBS journal.

[19]  N. Almond,et al.  Neuropathology of wild-type and nef-attenuated T cell tropic simian immunodeficiency virus (SIVmac32H) and macrophage tropic neurovirulent SIVmac17E-Fr in cynomolgus macaques , 2012, Journal of NeuroVirology.

[20]  A. Winston,et al.  Low Rates of Neurocognitive Impairment Are Observed in Neuro-Asymptomatic HIV-Infected Subjects on Effective Antiretroviral Therapy , 2011, HIV clinical trials.

[21]  J. Bell,et al.  Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals. , 2011, The American journal of pathology.

[22]  Susan Moir,et al.  Pathogenic mechanisms of HIV disease. , 2011, Annual review of pathology.

[23]  M. Maschke,et al.  Structural gray and white matter changes in patients with HIV , 2011, Journal of Neurology.

[24]  K. Kurz,et al.  Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy , 2010, Brain, Behavior, and Immunity.

[25]  R. Ownby,et al.  Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains , 2009, Journal of NeuroVirology.

[26]  M. Churchill,et al.  Extensive astrocyte infection is prominent in human immunodeficiency virus–associated dementia , 2009, Annals of neurology.

[27]  I. Grant,et al.  Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders , 2009, Neuropsychology Review.

[28]  S. Cocklin,et al.  The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors , 2008, Retrovirology.

[29]  David Pinson,et al.  Nonhuman primate models of NeuroAIDS , 2008, Journal of NeuroVirology.

[30]  R. Stebbings,et al.  Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8). , 2008, The Journal of general virology.

[31]  S. Rivest,et al.  Bone-marrow-derived microglia: myth or reality? , 2008, Current opinion in pharmacology.

[32]  Ross J. Harris,et al.  Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies , 2008, The Lancet.

[33]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[34]  Steven Wolinsky,et al.  Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia. , 2007, Virology.

[35]  I. Bechmann,et al.  IDO expression in the brain: a double-edged sword , 2007, Journal of Molecular Medicine.

[36]  Steven Wolinsky,et al.  The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia , 2006, Proceedings of the National Academy of Sciences.

[37]  D. Venzon,et al.  Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses. , 2006, Virology.

[38]  J. Mascola,et al.  Pathogenicity of Simian-Human Immunodeficiency Virus SHIV-89.6P and SIVmac Is Attenuated in Cynomolgus Macaques and Associated with Early T-Lymphocyte Responses , 2005, Journal of Virology.

[39]  M. Kaul,et al.  HIV-1 infection and AIDS: consequences for the central nervous system , 2005, Cell Death and Differentiation.

[40]  P. Romagnani,et al.  CXCR3-binding chemokines: novel multifunctional therapeutic targets. , 2005, Current drug targets. Immune, endocrine and metabolic disorders.

[41]  M. Churchill,et al.  Astrocyte specific viral strains in HIV dementia , 2004, Annals of neurology.

[42]  A. Nath,et al.  CD4-Independent Infection of Astrocytes by Human Immunodeficiency Virus Type 1: Requirement for the Human Mannose Receptor , 2004, Journal of Virology.

[43]  D. Venzon,et al.  Protection against Mucosal Simian Immunodeficiency Virus SIVmac251 Challenge by Using Replicating Adenovirus-SIV Multigene Vaccine Priming and Subunit Boosting , 2004, Journal of Virology.

[44]  W. Muller,et al.  The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection , 2003, Journal of leukocyte biology.

[45]  J. Clements,et al.  Expression of Simian Immunodeficiency Virus (SIV) Nef in Astrocytes during Acute and Terminal Infection and Requirement of Nef for Optimal Replication of Neurovirulent SIV In Vitro , 2003, Journal of Virology.

[46]  G. Bernardi,et al.  Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS , 2003, Journal of leukocyte biology.

[47]  Andrew V. Albright,et al.  Pathogenesis of human immunodeficiency virus-induced neurological disease , 2003, Journal of NeuroVirology.

[48]  J. Clements,et al.  The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. , 2002, The Journal of infectious diseases.

[49]  M. Weinand,et al.  Human Immunodeficiency Virus Type 1 Enters Brain Microvascular Endothelia by Macropinocytosis Dependent on Lipid Rafts and the Mitogen-Activated Protein Kinase Signaling Pathway , 2002, Journal of Virology.

[50]  P. Riederer,et al.  Parkinsonism in HIV dementia , 2002, Journal of Neural Transmission.

[51]  S. Majumder,et al.  Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation , 2000, Immunological reviews.

[52]  S. Weis,et al.  Neuronal damage of the substantia nigra in HIV-1 infected brains , 2000, Acta Neuropathologica.

[53]  J. Clements,et al.  High Viral Load in the Cerebrospinal Fluid and Brain Correlates with Severity of Simian Immunodeficiency Virus Encephalitis , 1999, Journal of Virology.

[54]  M. Weinand,et al.  Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. , 1999, The American journal of pathology.

[55]  H. Weiner,et al.  CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  E. Werner,et al.  Simultaneous measurement of serum tryptophan and kynurenine by HPLC. , 1997, Clinical chemistry.

[57]  J. Clements,et al.  Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus , 1997, Journal of virology.

[58]  Michael J. Taylor,et al.  The HNRC 500-Neuropsychology of Hiv infection at different disease stages , 1995, Journal of the International Neuropsychological Society.

[59]  L. Epstein.  Lentiviral encephalitides in the immature host: A comparison of human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) brain infection , 1989, Brain and Development.

[60]  M. Lederman,et al.  Residual immune dysregulation syndrome in treated HIV infection. , 2013, Advances in immunology.

[61]  Francisco González-Scarano,et al.  The neuropathogenesis of AIDS , 2005, Nature Reviews Immunology.

[62]  R. Ransohoff,et al.  Chemokine receptor CXCR3: an unexpected enigma. , 2005, Current topics in developmental biology.

[63]  P Bailey,et al.  Double Edged Sword , 2002 .